Engineering human tissues for drug discovery
BIO-Europe Spring Life Science symposium in Leiden
Together with the Leiden Bio Science Park (LBSP) based companies and the LBSP foundation, InnovationQuarter hosted a symposium, a side event to the BIO-Europe Spring on March 15th at the Leiden Bio Science Park. At this event, we took 60 interested local and international participants from BIO-Europe Spring along the exciting developments in the fields of engineered human tissues for drug discovery.
The event featured inspiring presentations from Leiden entrepeneurs Paul Vulto (Mimetas), Stefan Braam (Ncardia) and Leo Price (Ocello) regarding their specialized tissue models. This was followed by presentations from 3 multinational life science companies in the Leiden cluster Michela Tessari (Galapagos), Jeroen De Groot (Charles River) and Ivan Kopljar (J&J) to explain the business value of using these models in their drug discovery programs.
After the presentations, InnovationQuarter offered a networking lunch where all participants had the opportunity to meet each other and where several companies from the LBSP could provide information to the attendees.
Life Science cluster
Leiden Bio Science Park is one of the five largest bioscience parks in Europe and the largest in The Netherlands. It excels in therapeutics R&D and offers a broad range of biotech service companies, especially in the area of Regenerative Medicine and Tissue Engineering where there are many innovative developments.
The twelfth annual BIO-Europe Spring international partnering conference at the Amsterdam RAI, last week hosted 2,500 attendees from the life sciences who engaged in 14,500 one-to-one partnering. The event welcomed 1,426 companies overall, including over 250 delegates from the Netherlands Life Science sector.